![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, December 07, 2003 12:04:53 AM
There is also a connection back to Zengen through Lee's Pharmaceuticals. For instance Zengen owns 3.3% of Lee's and James Lipton (Zengen CSO) is on Lee's Scientific Advisory Board. Lee's are also involved with a pre-clinical study using Zengen's peptide technology. Lee's have an interesting multi-faceted relationship with both Zengen and PRB, and potentially offer a gateway to Greater China.
You might notice that there is also a "focus" on eye disease amongst some of the PRB Scientific Advisors and the CSO...
What do PRB/Lee's have that we want? That remains to be seen, but I think there are several possible ways that this could develop and there is certainly plenty of scope for synergy.
BTW, I know for a fact that W2P has been waiting for months for the PRB website to be completed!
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM